Cart
sales@molnova.com
Home - Products - Wnt/Notch/Hedgehog - Wnt/beta/catenin - Nesuparib

Nesuparib

CAS No. 2055357-64-5

Nesuparib( —— )

Catalog No. M35605 CAS No. 2055357-64-5

Nesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 233 In Stock
5MG 211 In Stock
10MG 337 In Stock
25MG 605 In Stock
50MG 807 In Stock
100MG 1097 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Nesuparib
  • Note
    Research use only, not for human use.
  • Brief Description
    Nesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.
  • Description
    Nesuparib is a potent inhibitor of PARP. Nesuparib is useful for the research of neuropathic pain, neurodegenerative disease, and cardiovascular disease (extracted from patent WO2016200101A2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    Wnt/beta-catenin | PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2055357-64-5
  • Formula Weight
    400.48
  • Molecular Formula
    C23H24N6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 62.5 mg/mL (156.06 mM )
  • SMILES
    O=c1[nH]c2cc(CN3CCN(CC3)c3ccc(cn3)C#N)ccc2c2NCCCc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same. Patent WO2016200101A2.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • WIC1

    WIC1 is a potent Wnt inhibitor. WIC1 can be used in cancer research

  • ICG-001

    ICG-001 is an antagonist of Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CBP) with IC50 of 3 μM.

  • β-Elemonic Acid

    Beta-Elemonic acid inhibits proliferation by inducing hypoploid cells and cell apoptosis, the anticancer effects of beta-Elemonic acid are related to the MAPK signaling pathway, ROS activation and glutathione depletion in human A549 lung cancer cells.

Sign In Join Free